Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
about
Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme.Temozolomide and radiotherapy versus radiotherapy alone in high grade gliomas: a very long term comparative study and literature review.Direct detection and quantification of abasic sites for in vivo studies of DNA damage and repair.Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors.Targeting Tregs in Malignant Brain Cancer: Overcoming IDO.New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection.
P2860
Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial.
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Temozolomide in radio-chemothe ...... orme: phase II clinical trial.
@ast
Temozolomide in radio-chemothe ...... orme: phase II clinical trial.
@en
type
label
Temozolomide in radio-chemothe ...... orme: phase II clinical trial.
@ast
Temozolomide in radio-chemothe ...... orme: phase II clinical trial.
@en
prefLabel
Temozolomide in radio-chemothe ...... orme: phase II clinical trial.
@ast
Temozolomide in radio-chemothe ...... orme: phase II clinical trial.
@en
P2093
P1433
P1476
Temozolomide in radio-chemothe ...... orme: phase II clinical trial.
@en
P2093
A Vecchione
C Campanella
F M Gagliardi
G Innocenzi
G Lanzetta
P304
P407
P577
2003-11-01T00:00:00Z